2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions

Jump to: View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

Abstract Number: 2895

Habitual Running Any Time in Life Is Not Detrimental and May be Protective of Symptomatic Knee Osteoarthritis: Data from the Osteoarthritis Initiative
Abstract Number: 2201

Haematological Complications in Rheumatic Diseases: Not Only Lymphomas
Abstract Number: 1014

Harpagide, a Low Molecular Weight Natural Product, Suppresses IL-1â-Induced IL-6 Expression By Blocking the Activation of p38 MAPK and Transcription Factors CEBPâ and AP-1 in Primary Human Osteoarthritis Chondrocytes
Abstract Number: 2228

Has MRI an Added Value over Serum Creatine Kinase Measurement in Myositis?
Abstract Number: 2652

Headache in Patients with Systemic Lupus Erythematosus Is Associated with Reduced Cerebral Grey Matter Volume, but not with Measures of Glial Activation, Anti-NR2-, or Anti-P Antibodies
Abstract Number: 2621

Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus
Abstract Number: 1142

Healthcare Costs Associated with Serious Infections Among Biologic-Naïve Rheumatoid Arthritis Patients Initiating First-Line Biologic Treatment
Abstract Number: 866

Heart Rate Variability: An Inflammatory Biomarker in Systemic Lupus Erythematosus
Abstract Number: 1681

Heart Transplantation in 6 Patients with Systemic Sclerosis and a Primary Cardiac Involvement
Abstract Number: 647

Helminthes Derivative for Treating Lupus and Colitis in Mice Models
Abstract Number: 586

Helplessness in Coping Is Associated with Worse Patient Reported Outcomes Among Patients with Ankylosing Spondylitis: A Longitudinal Multi-Country Cohort Study
Abstract Number: 1027

Hematopoietic Cell Kinase (HCK) As a Novel Regulator of Fibroblast-like Synoviocyte Function in RA
Abstract Number: 820

Herpes Zoster Infection Risk in Auto-Immune and Inflammatory Diseases: Implications for Vaccination
Abstract Number: 1390

Heterogeneity in Cardiovascular Risk Factors, Event Rates and RA Disease Characteristics Among Patients with Rheumatoid Arthritis Across 10 Countries – Implications for CV Risk Assessment
Abstract Number: 1963

Hierarchical Role of PI3K/Akt/mTOR Signaling Cascade on: Tissue Inflammation, Organization and Angiogenesis in Autoimmune Arthritis
Abstract Number: 389

High 11B-HSD1 Activity Is Associated with Progression to Rheumatoid Arthritis in Patients with a New Onset of Inflammatory Arthritis
Abstract Number: 2899

High Dose Aspirin for Treating Kawasaki Disease – Outdated Myth or Effective Aid?
Abstract Number: 1697

High Frequency Skin Ultrasound Detects Subclinical Diffuse Dermal Involvement in Patients with Limited Cutaneous Systemic Sclerosis
Abstract Number: 51

High Incidence of Non-Vertebral Osteoporotic Fracture and Hip Fracture in Brazilian Low-Income Community-Dwelling Elderly: A Population-Based Prospective Cohort Analysis from the São Paulo Ageing & Health (SPAH) Study
Abstract Number: 795

High Interobserver Agreement on Ultrasonographic Findings in Patients with Large Vessel Vasculitis
Abstract Number: 1707

High Oxidative Stress in Fibrotic and Non-Fibrotic Skin of Patients with Systemic Sclerosis
Abstract Number: 56

High Prevalence of Cervical Malignant and Premalignant Lesions Among Women with Rheumatoid and Psoriatic Arthritis
Abstract Number: 2223

High Prevalence of Hepatitis C Virus Infection in a Japanese Inclusion Body Myositis Cohort
Abstract Number: 3008

High Prevalence of Subclinical Ultrasonographic Enthesopathy and Synovitis in Patients with Inflammatory Bowel Disease without Clinical Signs or Symptoms of Spondyloarthritis
Abstract Number: 1842

High Rates of Failure after Biological DMARD Discontinuation While in Remission in a Japanese Multi-Center Registry
Abstract Number: 560

High Sensitivity of the ASAS Classification Criteria in Patients with HLA-B27 Positive Undifferentiated Spondyloarthritis with Onset of Disease after Age 45
Abstract Number: 1649

High Specificity of Skin Immunoglobulin Deposits for diagnosing SLE in Patients with Lupus Nephritis
Abstract Number: 20

High Systemic LDL Cholesterol Levels during Experimental Osteoarthritis Lead to Increased Synovial Activation and Ectopic Bone Formation at End-Stage Osteoarthritis, While Excessive Levels Accelerate Development of Joint Pathology Already at Early-Stage Osteoarthritis
Abstract Number: 2453

High-Density Genotyping of Risk Loci in African Americans with RA
Abstract Number: 171

High-Protein Diet (Atkins Diet) and Uric Acid Response
Abstract Number: 2673

High-Throughput Sequencing of 219 Candidate Genes for Identification of SLE-Associated Risk Variants
Abstract Number: 2027

Higher Educational Level Correlates with Retarded Onset and Less Severe Disease in Rheumatoid Arthritis Patients
Abstract Number: 1220

Higher Inflammatory Response in Elderly Patients during Gout Attack
Abstract Number: 1401

Higher-Order Neuropsychological Deficits Are Frequent and Occur Early in RA and SLE: The Impact of Basic Processing Abilities on Psychological Well-Being
Abstract Number: 1968

Highly activated IL-23/Th17 axis and JAK2/STAT3 signal pathway in PBMC of active AS patients involve in pathogenesis of AS
Abstract Number: 216

Hip Adiposity, Not Local Knee Adiposity, Is Associated with Knee Pain Independent of Radiographic Osteoarthritis Severity
Abstract Number: 1169

Hippocampal Atrophy Is Associated with Anti-NR2 Antibodies in Patients with Systemic Lupus Erythematosus and Primary Sjögren’s Syndrome
Abstract Number: 2817

Histone Deacetylase One Contributes to the Auto-Aggressive Phenotype of Rheumatoid Arthritis
Abstract Number: 1005

Histone Lysine Demethylase KDM6A Mediates Joint Destruction in Osteoarthritic Knees By Epigenetic Disturbance of SOX9 Promoter and Histone H3K27
Abstract Number: 134

Histopathological Correlation of Ultrasound-Defined Active Synovitis in Patients with Rheumatoid Arthritis in Clinical Remission. Preliminary Results
Abstract Number: 627

HLA Markers for Disease Severity Are Associated with a Higher Burden of Atherosclerosis in Patients with Psoriatic Disease
Abstract Number: 1919

HLA-B27 Expression Shapes the Intestinal Microbiota
Abstract Number: 318

HLA-B27 Subtypes in Enthesitis Related Arthritis Category of Juvenile Idiopathic Arthritis
Abstract Number: 82

HLA-DPB1^*04:01 Confers Risk for PR3-ANCA Positive ANCA-Associated Vasculitis (AAV), but Protects Against MPO-ANCA Positive AAV, in a Japanese Population
Abstract Number: 775

HLA-DRB1 Alleles in Susceptibility to Giant Cell Arteritis: Literature Review and Meta-Analysis
Abstract Number: 1787

HLA-DRB1*01 Is Associated with Henoch- Schönlein Purpura in the Spanish Population
Abstract Number: 1900

HLA-DRB1*1101, Regulatory Variants of the MHC, and a Regulatory Region Near an Intergenic Long Noncoding RNA on Chromosome 1 Are Risk Factors for Systemic Juvenile Idiopathic Arthritis
Abstract Number: 644

HM-0523, a Novel Syk Inhibitor Blocks Glomerulonephritis and Extends Life Spans in Lupus Prone MRL/Lpr Mice
Abstract Number: 190

Hospital Volume Predicts Outcomes and Complications after Total Shoulder Arthroplasty
Abstract Number: 800

Hospitalization Rates and Utilization Among Patients with Giant Cell Arteritis: A Population-Based Study from 1987 to 2012
Abstract Number: 2116

Hospitalization Rates and Utilization Among Rheumatoid Arthritis Patients: A Population-Based Study from 1987 to 2012
Abstract Number: 2043

How Correct Are the Assumptions Made for Tuberculosis Screening Algorythms before TNF-Alpha Antagonists?
Abstract Number: 2544

How Does a Younger Age at the Onset of Sjögren’s Syndrome (pSS) Influence the Clinical Presentation and the Clinical Course of the Disease?
Abstract Number: 2257

How Does Non-Compliance to Prolia ® (DENOSUMAB) Impact the Change in Bone Mineral Density (BMD) in Osteoporotic Patients?
Abstract Number: 1061

How Does Rheumatoid Arthritis Disease Activity Affect Development of Upper Cervical Lesions? a Retrospective Study of Cervical Spine X-Rays Combined with a Cohort Study in Rheumatoid Arthritis Patients
Abstract Number: 701

How Important Is Physical Activity for Patients with Systemic Lupus Erythematodes? -Results of Lula-Study
Abstract Number: 906

How Long Does Sonographic Joint Activity Continue in Clinically Remittive Joints of Patients with Rheumatoid Arthritis?
Abstract Number: 383

How Low Is Low Disease Activity? an Analysis from a Prospective, Observational Registry
Abstract Number: 2229

How Often Are Clinically Amyopathic Dermatomyositis Patients Truly Amyopathic?
Abstract Number: 2579

How Should We Calculate the ASDAS If the Conventional C-Reactive Protein Is below the Limit of Detection? – an Analysis in the DESIR Cohort
Abstract Number: 2606

How to Classify Spondyloarthritis after a Two Year Follow up? Results from the French Recent onset spondyloarthritis Cohort
Abstract Number: 39

Human CD14⁺ Monocytes Stimulated with a Combination of TNFα and IL-6 Differentiate into Osteoclast-like Cells with Bone-Resorption Activity
Abstract Number: 2340

Human Osteoclasts Are Mobilized in Erosive Arthritis of Epstein-Barr Virus-Infected Humanized NOD/Shi-Scid/IL-2Rγ^null Mice
Abstract Number: 2809

Human Papilloma Virus and Chlamydia Trachomatis Infections in Rheumatoid Arthitis Under Anti-TNF Therapy
Abstract Number: 1753

Human T-Cells Express RANKL in Response to Combination of ZAP-70, Calcineurin and Voltage-Gated K+-Channel Signaling Following Co-Ligation of the Adhesion Molecule CD2 and the T-Cell Receptor Complex
Abstract Number: 2159

Human T-Lymphotropic Virus Type 1 Biomarkers in Patients with Rheumatoid Arthritis
Abstract Number: 2170

Human Tolerogenic Dendritic Cells Generated with Protein Kinase C Inhibitor Are Optimal for Regulatory T Cell Induction-a Comparative Study
Abstract Number: L23

Humoral Immune Response to Pneumococcal Polysaccharide Vaccine in SLE Patients on Immunosuppressive Therapy: Assessment of Serotypes without Protective Antibody Levels
Abstract Number: 706

Humoral Immunodeficiency in Patients Presenting with Clinical Features of Systemic Lupus Erythematosus
Abstract Number: 35

Hydrogen Sulfide Inhibits Human Osteoclast Differentiation in Vitro By Triggering Sustained Antioxidant Response and Inhibiting the RANKL/OPG Ratio
Abstract Number: 679

Hydroxychloroquine Dosing and Disease Activity in a Large Multi-Racial Lupus Cohort
Abstract Number: 681

Hydroxychloroquine Use Is Associated Independently with Improved Quality of Life in Systemic Lupus Erythematosus
Abstract Number: 655

Hydroxycholorquine Is Cardioprotective in an In Vivo Rat Model of Myocardial Ischaemic Reperfusion Injury
Abstract Number: 1922

Hydroxylchloroquine Use Is Associated with Decreased Soluble TNF Receptor Levels in SLE Patient Samples
Abstract Number: 1276

Hyperglycemia and Risk of Osteoarthritis
Abstract Number: 2074

Hypervigilance and FMS
Abstract Number: 2693

Hyporesponsiveness to TLR9 in Term of Cytokines Production By B Cells in SLE-Patients
Abstract Number: 1201

Hypoxia Modulates Peptidyl Arginine Deiminase 4 Activity and Neutrophil Extracellular Trap Formation

Jump to: View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].